GlassScriptPhysician profile
Arthur C Nilson
NPI 1558454165
$4,193.36
in general payments reported to CMS, 2019-2025
32 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $352 · 2021: $1,005 · 2022: $743 · 2023: $748 · 2024: $434 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,379 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,378.84 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,369.36 | 2019-2023 | |
| Daiichi Sankyo INC. | $828.42 | 2019-2025 | Injectafer |
| Astellas Pharma US INC | $321.50 | 2023-2025 | Veozah |
| Intuitive Surgical, INC. | $199.83 | 2022-2024 | Da Vinci Surgical System |
| Organon LLC | $131.91 | 2022-2025 | Nexplanon |
| Therapeuticsmd, INC. | $126.00 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.69 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $104.00 | 2023 | |
| Millicent US INC | $92.99 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Sumitomo Pharma America, INC. | $88.57 | 2023-2025 | Myfembree |
| Avion Pharmaceuticals | $87.28 | 2019-2023 | Balcoltra |
| Hologic Sales and Service, LLC | $86.99 | 2024 | Myosure Tissue Removal Device, Thinprep 2000 Processor, Aptima |
| Exeltis, USA INC. | $68.90 | 2019-2021 | |
| Pfizer INC. | $61.25 | 2024-2025 | |
| Myovant Sciences INC. | $54.98 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $54.29 | 2019-2021 | |
| Minerva Surgical, INC | $47.73 | 2024 | |
| Agile Therapeutics, INC. | $40.19 | 2021-2022 | |
| Medtronic, INC. | $32.45 | 2023-2024 | Ligasure, Truclear |
| Exact Sciences Corporation | $30.99 | 2023-2025 | Cologuard Collection Kit |
| Roche Diagnostics Corporation | $29.06 | 2019 | |
| Coopersurgical, INC. | $28.65 | 2024 | Endosee |
| Amag Pharmaceuticals, INC. | $28.02 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $24.05 | 2023 | Ultomiris |
| Allergan, INC. | $23.42 | 2019 | |
| Mission Pharmacal Company | $22.04 | 2020 | |
| Mylan Pharmaceuticals INC. | $21.72 | 2021 | |
| Baxter Healthcare | $21.16 | 2025 | Perclot |
| Axonics, INC. | $20.46 | 2024 | Bulkamid |
| Lupin INC. | $16.28 | 2019 | |
| Acessa Health INC. | $12.70 | 2019 | |
| Virtus Pharmaceuticals LLC | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Nilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.